Literature DB >> 28447419

Controversies in the diagnosis of Type 1 von Willebrand disease.

M L Bowman1, P D James1,2.   

Abstract

von Willebrand disease (VWD) is the most common bleeding disorder. Type 1 VWD represents the majority of cases and results from a partial quantitative deficiency of von Willebrand factor (VWF). The diagnosis of Type 1 VWD presents many challenges, despite there being three established diagnostic criteria: a personal history of mucocutaneous bleeding, a family history and low VWF levels. These criteria do not always coexist, and there is great overlap of clinical phenotypes and laboratory parameters between healthy individuals and those with VWD. Mild bleeding symptoms can have any number of causes and bleeding is commonly reported in the general population. VWF levels do not always correlate with bleeding symptoms and can be variable between affected family members. Additionally, VWF levels vary widely as a result of both genetic and non-genetic influences. Perhaps the greatest current controversy in the diagnosis of Type 1 VWD is that there is no consensus laboratory cut-off for the diagnosis, raising concern about both over- and under-diagnosis. Ongoing studies are addressing these issues by clarifying the underlying pathogenesis of the disease, as well as the natural history and the risk of future bleeding in those with the diagnosis.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  diagnosis; von Willebrand disease; von Willebrand factor

Mesh:

Year:  2017        PMID: 28447419     DOI: 10.1111/ijlh.12653

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  6 in total

1.  Cryptogenic oozers and bruisers.

Authors:  Kristi J Smock; Karen A Moser
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  New developments in von Willebrand disease.

Authors:  Helen Fogarty; Dearbhla Doherty; James S O'Donnell
Journal:  Br J Haematol       Date:  2020-05-12       Impact factor: 6.998

3.  Targeted re-sequencing of F8, F9 and VWF: Characterization of Ion Torrent data and clinical implications for mutation screening.

Authors:  Eric Manderstedt; Rosanna Nilsson; Christina Lind-Halldén; Rolf Ljung; Jan Astermark; Christer Halldén
Journal:  PLoS One       Date:  2019-04-26       Impact factor: 3.240

4.  Closing the gap - detection of clinically relevant von Willebrand disease in emergency settings through an improved algorithm based on rotational Thromboelastometry.

Authors:  H-G Topf; E R Strasser; G Breuer; W Rascher; M Rauh; F B Fahlbusch
Journal:  BMC Anesthesiol       Date:  2019-01-10       Impact factor: 2.217

5.  Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding.

Authors:  Ferdows Atiq; Esmee Wuijster; Moniek P M de Maat; Marieke J H A Kruip; Marjon H Cnossen; Frank W G Leebeek
Journal:  J Thromb Haemost       Date:  2021-01-24       Impact factor: 5.824

Review 6.  Congenital Bleeding Disorders amid the COVID-19 pandemic: Open questions and recommendations.

Authors:  Majid Naderi; Fatemeh Malek; Ghasem Miri Aliabad; Mahammad Behnampoor; Mehran Karimi; Vincenzo De Sanctis
Journal:  Acta Biomed       Date:  2020-09-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.